Relationship between the HDL-C/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from Yunnan Province, China

Objective To clarify whether the high-density lipoprotein cholesterol/C reactive protein (HDL-C/CRP) ratio can be used as a new prognosticator of all-cause mortality in patients with chronic heart failure (CHF) (New York Heart Association (NYHA) cardiac class III/IV).Design Retrospective study.Backg...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenyi Gu, Tao Shi, Xiongyi Liuzhuang, Sirui Yang, Yunhong Yang, Chenggong Xu, Lixing Chen
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/3/e084099.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850089042462375936
author Wenyi Gu
Tao Shi
Xiongyi Liuzhuang
Sirui Yang
Yunhong Yang
Chenggong Xu
Lixing Chen
author_facet Wenyi Gu
Tao Shi
Xiongyi Liuzhuang
Sirui Yang
Yunhong Yang
Chenggong Xu
Lixing Chen
author_sort Wenyi Gu
collection DOAJ
description Objective To clarify whether the high-density lipoprotein cholesterol/C reactive protein (HDL-C/CRP) ratio can be used as a new prognosticator of all-cause mortality in patients with chronic heart failure (CHF) (New York Heart Association (NYHA) cardiac class III/IV).Design Retrospective study.Background Several papers have revealed that HDL-C and CRP can act as anti-inflammatory and pro-inflammatory factors, respectively, to affect disease progression in patients with heart failure, and the balance of the two has been shown to affect the prognosis of patients with heart failure with preserved ejection fraction (HFpEF), but none of the above studies involved patients with the more severe forms of heart failure with mildly reduced ejection fraction and heart failure with reduced ejection fraction; therefore, the present study is to extend the balance of HDL-C and CRP to the whole range of types of patients CHF to further confirm its importance.Setting This study is from a single centre in Yunnan Province, China.Participants After excluding ineligible patients, we finally included 1192 patients with CHF from January 2017 to October 2021.Primary and secondary measures The primary outcome was all-cause mortality in patients with CHF between January 2017 and October 2021. No secondary outcome measures were performed.Results All patients were divided into four groups according to the quartiles of the HDL-C/CRP ratio. Using the Kaplan-Meier analysis, the risk of all-cause mortality was always the highest for Q1 (HDL-C/CRP<0.395) and the lowest for group Q4 (HDL-C/CRP≥3.4163). Cox univariate and multivariate regression analyses showed that HDL-C/CRP was consistently an independent risk factor for death from CHF. Based on the receiver operating characteristic curve, the area under the curve for HDL-C/CRP was 0.7254 (p<0.001), with a sensitivity of 65.5% and a specificity of 69.6%.Conclusions The HDL-C/CRP ratio is an independent prognostic indicator of all-cause mortality in patients with CHF in NYHA cardiac function class III/IV, which has good specificity and sensitivity. Patients with lower levels of the HDL-C/CRP ratio are at a greater risk of death than patients with higher levels of the HDL-C/CRP ratio.
format Article
id doaj-art-b4b8f705ef3443428f64fe62d1df3c2e
institution DOAJ
issn 2044-6055
language English
publishDate 2025-03-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-b4b8f705ef3443428f64fe62d1df3c2e2025-08-20T02:42:52ZengBMJ Publishing GroupBMJ Open2044-60552025-03-0115310.1136/bmjopen-2024-084099Relationship between the HDL-C/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from Yunnan Province, ChinaWenyi Gu0Tao Shi1Xiongyi Liuzhuang2Sirui Yang3Yunhong Yang4Chenggong Xu5Lixing Chen6Department of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, ChinaDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, ChinaDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, ChinaDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, ChinaDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, ChinaDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, ChinaDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, ChinaObjective To clarify whether the high-density lipoprotein cholesterol/C reactive protein (HDL-C/CRP) ratio can be used as a new prognosticator of all-cause mortality in patients with chronic heart failure (CHF) (New York Heart Association (NYHA) cardiac class III/IV).Design Retrospective study.Background Several papers have revealed that HDL-C and CRP can act as anti-inflammatory and pro-inflammatory factors, respectively, to affect disease progression in patients with heart failure, and the balance of the two has been shown to affect the prognosis of patients with heart failure with preserved ejection fraction (HFpEF), but none of the above studies involved patients with the more severe forms of heart failure with mildly reduced ejection fraction and heart failure with reduced ejection fraction; therefore, the present study is to extend the balance of HDL-C and CRP to the whole range of types of patients CHF to further confirm its importance.Setting This study is from a single centre in Yunnan Province, China.Participants After excluding ineligible patients, we finally included 1192 patients with CHF from January 2017 to October 2021.Primary and secondary measures The primary outcome was all-cause mortality in patients with CHF between January 2017 and October 2021. No secondary outcome measures were performed.Results All patients were divided into four groups according to the quartiles of the HDL-C/CRP ratio. Using the Kaplan-Meier analysis, the risk of all-cause mortality was always the highest for Q1 (HDL-C/CRP<0.395) and the lowest for group Q4 (HDL-C/CRP≥3.4163). Cox univariate and multivariate regression analyses showed that HDL-C/CRP was consistently an independent risk factor for death from CHF. Based on the receiver operating characteristic curve, the area under the curve for HDL-C/CRP was 0.7254 (p<0.001), with a sensitivity of 65.5% and a specificity of 69.6%.Conclusions The HDL-C/CRP ratio is an independent prognostic indicator of all-cause mortality in patients with CHF in NYHA cardiac function class III/IV, which has good specificity and sensitivity. Patients with lower levels of the HDL-C/CRP ratio are at a greater risk of death than patients with higher levels of the HDL-C/CRP ratio.https://bmjopen.bmj.com/content/15/3/e084099.full
spellingShingle Wenyi Gu
Tao Shi
Xiongyi Liuzhuang
Sirui Yang
Yunhong Yang
Chenggong Xu
Lixing Chen
Relationship between the HDL-C/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from Yunnan Province, China
BMJ Open
title Relationship between the HDL-C/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from Yunnan Province, China
title_full Relationship between the HDL-C/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from Yunnan Province, China
title_fullStr Relationship between the HDL-C/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from Yunnan Province, China
title_full_unstemmed Relationship between the HDL-C/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from Yunnan Province, China
title_short Relationship between the HDL-C/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from Yunnan Province, China
title_sort relationship between the hdl c crp ratio and all cause mortality in patients with chronic heart failure a retrospective analysis from yunnan province china
url https://bmjopen.bmj.com/content/15/3/e084099.full
work_keys_str_mv AT wenyigu relationshipbetweenthehdlccrpratioandallcausemortalityinpatientswithchronicheartfailurearetrospectiveanalysisfromyunnanprovincechina
AT taoshi relationshipbetweenthehdlccrpratioandallcausemortalityinpatientswithchronicheartfailurearetrospectiveanalysisfromyunnanprovincechina
AT xiongyiliuzhuang relationshipbetweenthehdlccrpratioandallcausemortalityinpatientswithchronicheartfailurearetrospectiveanalysisfromyunnanprovincechina
AT siruiyang relationshipbetweenthehdlccrpratioandallcausemortalityinpatientswithchronicheartfailurearetrospectiveanalysisfromyunnanprovincechina
AT yunhongyang relationshipbetweenthehdlccrpratioandallcausemortalityinpatientswithchronicheartfailurearetrospectiveanalysisfromyunnanprovincechina
AT chenggongxu relationshipbetweenthehdlccrpratioandallcausemortalityinpatientswithchronicheartfailurearetrospectiveanalysisfromyunnanprovincechina
AT lixingchen relationshipbetweenthehdlccrpratioandallcausemortalityinpatientswithchronicheartfailurearetrospectiveanalysisfromyunnanprovincechina